Original Research
Published on 07 May 2026
Evaluating the impact of leniolisib treatment on symptoms and health-related quality of life in activated phosphoinositide 3-kinase delta (PI3Kδ) syndrome
in Primary Immunodeficiencies
- 571 views
Original Research
Published on 07 May 2026
in Primary Immunodeficiencies
Original Research
Published on 07 May 2026
in Experimental Therapeutics
Original Research
Published on 07 May 2026
in Digital Impacts
Original Research
Published on 07 May 2026
in Thyroid Endocrinology
Original Research
Published on 07 May 2026
in Digital Education
Editorial
Published on 07 May 2026
in Hepatobiliary Diseases
Original Research
Published on 07 May 2026
in Educational Psychology
Brief Research Report
Published on 07 May 2026
in Rheumatology
Original Research
Published on 07 May 2026
in Water and Climate
Review
Published on 07 May 2026
in Atherosclerosis and Vascular Medicine
Original Research
Published on 07 May 2026
in Ethnopharmacology
Review
Published on 07 May 2026
in Neurosurgery
Original Research
Published on 07 May 2026
in Psychology for Clinical Settings
Case Report
Published on 07 May 2026
in Vascular Surgery
Original Research
Published on 07 May 2026
in Terrestrial Microbiology
Systematic Review
Published on 07 May 2026
in Coronary Artery Disease